Development of a carrier system containing hyaluronic acid and protamine for siRNA delivery in the treatment of melanoma
{{output}}
The use of small interfering RNA (siRNA) in melanoma treatment remains limited owing to its biological properties. Herein, we developed a carrier system containing hyaluronic acid and protamine for siRNA delivery. Considering zeta potential and particle size a... ...
